| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | procarbazine | CTRPv2 | pan-cancer | AAC | -0.0051 | 0.9 |
| mRNA | fingolimod | CTRPv2 | pan-cancer | AAC | -0.0043 | 0.9 |
| mRNA | Nutlin-3a (-) | GDSC1000 | pan-cancer | AAC | 0.0033 | 0.9 |
| mRNA | FMK | GDSC1000 | pan-cancer | AAC | 0.0036 | 0.9 |
| mRNA | Methotrexate | FIMM | pan-cancer | AAC | 0.013 | 0.9 |
| mRNA | Nilotinib | GDSC1000 | pan-cancer | AAC | 0.0031 | 0.9 |
| mRNA | gossypol | CTRPv2 | pan-cancer | AAC | -0.0035 | 0.9 |
| mRNA | Epothilone B | FIMM | pan-cancer | AAC | 0.015 | 0.9 |
| mRNA | Bortezomib | CTRPv2 | pan-cancer | AAC | 0.0031 | 0.9 |
| mRNA | BMS-754807 | GDSC1000 | pan-cancer | AAC | 0.0026 | 0.9 |